发明名称 |
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS |
摘要 |
Provided herein are methods for alleviating symptoms in a subject having a neurodegenerative disorder, comprising administering to the subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D) or to its Plexin-B1 or Plexin-B2 receptors. |
申请公布号 |
US2015353641(A1) |
申请公布日期 |
2015.12.10 |
申请号 |
US201514753882 |
申请日期 |
2015.06.29 |
申请人 |
VACCINEX, INC. |
发明人 |
Smith Ernest S.;Zauderer Maurice;Bowers William J.;Jonason Alan |
分类号 |
C07K16/28;A61K45/06;A61K39/395 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of alleviating symptoms in a subject having, or suspected of having, Huntington's disease (HD), comprising administering to the subject an effective amount of an isolated binding molecule that specifically binds to semaphorin-4D (SEMA4D). |
地址 |
Rochester NY US |